dactinomycin has been researched along with cefepime in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C | 1 |
| Akiyama, K; Endo, H; Hiramatsu, N; Koyama, T; Nishinari, C; Suzuki, Y | 2 |
| Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T | 2 |
| Azuma, H; Kobayashi, R; Sano, H; Sarashina, T; Suzuki, D; Toriumi, N; Yoshida, M | 1 |
| Akiyama, N; Fukushima, T; Hatanaka, K; Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Nakane, T; Ohyashiki, K; Takahashi, T; Tamaki, T; Tamura, K; Tanimoto, M; Tatsumi, Y; Urabe, A; Yoshida, I | 1 |
| Miyamura, K; Mori, K; Mukoyama, N; Nakashima, M; Noda, Y; Yoshimi, A | 1 |
| Esumi, S; Higashionna, T; Kitamura, Y; Murakawa, K; Sendo, T; Ushio, S | 1 |
1 review(s) available for dactinomycin and cefepime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for dactinomycin and cefepime
| Article | Year |
|---|---|
A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms | 2014 |
Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins; Young Adult | 2015 |
8 other study(ies) available for dactinomycin and cefepime
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins | 2001 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--I. Gram-positive bacteria].
Topics: Cefepime; Cefozopran; Cephalosporins; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus | 2003 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
Topics: Cefepime; Cefoperazone; Cefozopran; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Moraxella | 2003 |
Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients.
Topics: Abdomen; Anti-Bacterial Agents; Ascitic Fluid; Cefepime; Cefotiam; Cefozopran; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Laparotomy; Microbial Sensitivity Tests; Monte Carlo Method; Postoperative Complications; Surgical Wound Infection | 2008 |
Determination of total cefozopran concentrations in human peritoneal fluid by HPLC with cefepime as an internal standard: Comparative pharmacokinetics in the fluid and plasma.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefepime; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Reference Standards; Reproducibility of Results; Ultrafiltration | 2009 |
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Male; Middle Aged; Piperacillin; Retrospective Studies | 2017 |
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer.
Topics: Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Febrile Neutropenia; Humans; Lung Neoplasms; Retrospective Studies; Treatment Outcome | 2022 |